Increasing the output of Haikou pharmaceutical enterprises and the average output of land

The average output of Chang'an international pharmaceutical field is 21.1 million yuan / mu, Qilu pharmaceutical field is 11.93 million yuan / mu, hailing pharmaceutical field is 8.81 million yuan / mu Nowadays, in Haikou pharmaceutical Valley, Hainan Province, a group of high-tech enterprises with core competitiveness have been formed and expanded Through technological transformation and technological innovation, they have improved their ability of independent innovation, injected vitality into every inch of land, and achieved the maximum benefit with the least land output At present, Hainan Chang'an International Pharmaceutical Co., Ltd is mainly engaged in the production and management of pharmaceutical raw materials and preparations, and more than 80 new drugs are produced and under research, mainly involving five categories of anti-tumor, cardio cerebrovascular disease and anti infection In particular, the antineoplastic drug, lobaplatin, has a leading position in China and is also the main product of the enterprise In 2013, Changan International Pharmaceutical Co., Ltd created more than 250 million yuan of output value "We take a small and precise development path with high input and output and controllable risk We mainly produce some products with high added value, so our local average output is relatively high." Dr Sui Donghu, deputy general manager of Hainan Chang'an International Pharmaceutical Co., Ltd., said that last year, they produced more than 250 million yuan of output value on 12 mu of precious land, with the least land to produce the greatest benefit According to Sui Donghu, in the future development direction, Hainan Chang'an International Pharmaceutical Co., Ltd will continue to take the road of scientific and technological innovation and expand its space, especially in "lobaplatin", carry out re research and development, improve and optimize its production process, expand its clinical indications, strive to achieve the goal of "lobaplatin" output value reaching 1 billion yuan through 3-5 years' efforts In 2013, the average output of enterprises in Haikou high tech Zone ranked second with 11.93 million yuan / mu According to the introduction, after the second phase of the project was put into use last year, there were two production lines and four varieties were put into production The sales revenue reached 829 million output value, an increase of 135.73% The output value growth was the fastest in the park "We are also increasing investment in R & D, with more than 30 varieties in R & D," said Sun Denghua, manager of supply and marketing department of Qilu pharmaceutical In recent years, with the development of Haikou pharmaceutical manufacturing industry, Haikou pharmaceutical manufacturing industry has achieved rapid growth The pharmaceutical manufacturing industry has become the industry with the best, fastest and most stable growth In 2013, 55 normal production pharmaceutical enterprises in the city completed the first breakthrough of 10 billion yuan in total industrial output value in 2013 As a precedent for Haikou to practice green development, 49 industrial enterprises have gathered in the core area of Haikou pharmaceutical valley At present, there are 200 enterprises in Haikou high tech Zone, of which 149 have been put into production In 2013, the average output of pharmaceutical enterprises in the park was 3.15 million yuan / mu Among the enterprises in the park, there are 23 enterprises whose output reaches the output value standard of the high tech Zone (2 million yuan / mu) In addition to Chang'an International Pharmaceutical Co., Ltd and Qilu Pharmaceutical Co., Ltd., there are also pharmaceutical enterprises such as Hailing Pharmaceutical Co., Ltd., vante Pharmaceutical Co., Ltd and zambond Pharmaceutical Co., Ltd., all of which are above 8 million yuan / mu Zhu Donghai, director of the Management Committee of Haikou national high tech Zone, said that from the central government to the local government, there is a strong demand for land conservation The same is true of high tech zones In terms of land use, the policy has always been to use the least land to produce the largest output value In the next step, the high-tech zone will provide policy incentives to the enterprises with high output per capita, realize "both fame and wealth", and also require the enterprises with low output per capita to rectify and implement the survival of the fittest.